What are Triptan drugs?

Triptan drugs are pharmacologic agents that share a common mechanism (typically targeting 5-HT1B/1D receptors). 1 are currently marketed, with 2 more in clinical development.

What are the marketed Triptan drugs?

Marketed Triptan drugs include ALMOTRIPTAN MALATE.

Triptan

1 marketed 1 in Phase 3 1 in Phase 2

This page covers all Triptan drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting 5-HT1B/1D receptors, 5-HT1B, 5-HT1D, 5-HT1B and 5-HT1D receptors.

Targets

5-HT1B/1D receptors · 5-HT1B, 5-HT1D · 5-HT1B and 5-HT1D receptors

Marketed (1)

ALMOTRIPTAN MALATE · Neuroscience
Almotriptan malate is a selective 5-HT1B/1D receptor agonist that binds with high affinity to these receptors, leading to vasoconstriction and inhibition of neurogenic inflammation.

Phase 3 pipeline (1)

standard IV treatment for headache · HCA Florida North Florida Hospital · Neurology
Sumatriptan works by binding to serotonin receptors, specifically 5-HT1B and 5-HT1D receptors, to induce vasoconstriction and inhibit pro-inflammatory neuropeptide release.

Phase 2 pipeline (1)

Exposure to Triptan · Assistance Publique Hopitaux De Marseille · Neurology
Triptans are a class of drugs that work by stimulating serotonin receptors in the brain, leading to the dilation of blood vessels and the relief of migraine symptoms.